CD20 CD3 bispecific 썸네일형 리스트형 What Is a Bispecific Antibody? — A Simple Guide for Lymphoma Patients What Is a Bispecific Antibody?If you have been reading about newer lymphoma treatments recently, you have probably come across this term. Bispecific antibody. It shows up in articles about Lunsumio. It shows up in articles about Epcoritamab. It is becoming one of the most important concepts in lymphoma treatment right now — and once you understand how it works, a lot of things start to make sens.. 더보기 Epcoritamab (Epkinly) — A New Treatment Option for Relapsed Follicular Lymphoma Epcoritamab (Epkinly): Another Option on the HorizonFollicular Lymphoma is a rare disease. New treatment approvals don't come often — which is why I pay attention when they do. I am a Stage 4 Follicular Lymphoma patient on my second relapse. Epcoritamab is not my next treatment. But I track every new option that appears, because options are what matter when you are running out of them. What Is E.. 더보기 Lunsumio (Mosunetuzumab): What I Learned Researching My Own Next Treatment When I searched for information about Lunsumio as a relapsed Follicular Lymphoma patient, I found press releases from pharmaceutical companies. Clinical trial summaries written for oncologists. Almost nothing written by or for patients. So I researched it myself. This is what I found. Who I Am and Why I Wrote ThisI have Stage 4 Follicular Lymphoma, Grade 3A. Diagnosed February 2021. R-CHOP for f.. 더보기 이전 1 다음
